Clinical trial
Safety and Efficacy of Different Oral Doses of BAY94-8862 in Japanese Subjects…
NCT01968668 · Bayer, Industry · Completed
Key facts
| NCT number | NCT01968668 |
|---|---|
| Title | Safety and Efficacy of Different Oral Doses of BAY94-8862 in Japanese Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Nephropathy (ARTS-DN Japan) |
| Official title | A Randomized, Double-blind, Placebo-controlled, Multi-center Study to Assess the Safety and Efficacy of Different Oral Doses of BAY94-8862 in Japanese Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Nephropathy |
| Lead sponsor | Bayer, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Diabetic Nephropathies |
| Intervention type | Drug |
| Interventions | BAY94-8862, Placebo, BAY 94-8862 |
| Enrollment | 96 |
| Start date | Oct 28, 2013 |
| Primary completion | Oct 9, 2014 |
| Completion | Nov 7, 2014 |
| First posted | Oct 24, 2013 |
| Last update posted | Jul 16, 2021 |
| Countries | Japan |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: